Clinical Trials Browser

Phase NA × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Mycophenolic Acid × Clear all

Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00594308 2014-10-06

In-Vivo Activated T-Cell Depletion to Prevent GVHD

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

Clinical Trials

Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy

In-Vivo Activated T-Cell Depletion to Prevent GVHD